Internal Medicine · San Francisco, CA
NPI
1861597932
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3838 California St, Suite 508
San Francisco, CA, 94118
Phone (415) 831-9788
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
397 services
Medicare patients, 2024
191
Average age 78
Drug cost, 2024
$1.5M
4,848 prescriptions
Company payments, 2025
$14.17
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Crawford Chung was code 99214 (office e&m - established), 222 times for 140 patients. In total Crawford Chung billed 397 services in 7 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 222 | 140 | $100.90 | $22K |
| 99213 Office E&M - Established | Office | 115 | 52 | $61.41 | $7,062 |
| 99205 Office E&M - New | Office | 30 | 30 | $198.43 | $5,953 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 27 | 27 | $151.30 | $4,085 |
By year: 2022 $79K for 727 services; 2023 $60K for 540 services; 2024 $40K for 397 services.
Medicare prescription drug claims, 2024
In 2024, the drug Crawford Chung prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 711 prescriptions and refills. In total Crawford Chung wrote 4,848 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 711 | 1,086 | 176 | $667K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 393 | 510 | 129 | $16K |
| Amlodipine Besylate Generic | 208 | 607 | 55 | $1,193 |
| Atorvastatin Calcium Generic | 190 | 568 | 54 | $1,660 |
| Azithromycin Generic | 172 | 187 | 105 | $449 |
| Montelukast Sodium Generic | 145 | 431 | 50 | $1,503 |
| Breo Ellipta Fluticasone/Vilanterol | 122 | 236 | 41 | $88K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 121 | 205 | 30 | $96K |
| Losartan Potassium Generic | 121 | 331 | 33 | $811 |
| Albuterol Sulfate Generic | 109 | 220 | 31 | $18K |
| Metformin Hcl Generic | 100 | 277 | 29 | $627 |
| Metoprolol Succinate Generic | 93 | 279 | 27 | $1,339 |
| Amoxicillin Generic | 85 | 87 | 18 | $111 |
| Prednisone Generic | 85 | 107 | 48 | $282 |
| Furosemide Generic | 70 | 142 | 16 | $230 |
Brand drugs: - claims; generic drugs: 3,088 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Crawford Chung $14.17 ($14.17 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $14.17.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $14.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.